Argan oil improves surrogate markers of CVD in humans.

Souad Sour, Meriem Belarbi, Darine Khaldi, Nassima Benmansour, Nassima Sari, Abdelhafid Nani, Farid Chemat, Francesco Visioli

Journal: The British journal of nutrition 2012;107(12):1800-5

PMID: 22082585

Abstract

Limited - though increasing - evidence suggests that argan oil might be endowed with potential healthful properties, mostly in the areas of CVD and prostate cancer. We sought to comprehensively determine the effects of argan oil supplementation on the plasma lipid profile and antioxidant status of a group of healthy Algerian subjects, compared with matched controls. A total of twenty healthy subjects consumed 15 g/d of argan oil - with toasted bread - for breakfast, during 4 weeks (intervention group), whereas twenty matched controls followed their habitual diet, but did not consume argan oil. The study lasted 30 d. At the end of the study, argan oil-supplemented subjects exhibited higher plasma vitamin E concentrations, lower total and LDL-cholesterol, lower TAG and improved plasma and cellular antioxidant profile, when compared with controls. In conclusion, we showed that Algerian argan oil is able to positively modulate some surrogate markers of CVD, through mechanisms which warrant further investigation.

Address: Natural Products Laboratory, Department of Biology, Faculty of Natural and Life Sciences and Sciences of Earth and Universe, Abu Bakr Belkaid University, Tlemcen, Algeria.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.